单酰甘油脂肪酶在物质使用中的作用:临床前研究系统综述
该系统综述遵循PRISMA 2020指南,纳入42项临床前研究,评估物质暴露对MAGL表达或活性的影响以及操纵MAGL功能对SUD相关结局的作用。慢性物质暴露引起轻度、区域特异性的MAGL蛋白表达变化;MAGL抑制持续减少大麻、阿片和尼古丁模型的戒断样行为,但对奖赏相关行为的影响不一。
要点
- 慢性物质暴露引起区域特异性MAGL蛋白表达变化,海马中酒精增加MAGL水平。
- MAGL抑制持续减少大麻、阿片和尼古丁模型的戒断样行为。
- MAGL抑制对奖赏相关行为影响不一,减少阿片相关奖赏但其他模型不一致。
核心结论
- 临床前SUD模型提示MAGL在戒断样状态中的作用比在奖赏中更稳健。
研究设计与样本
- 遵循PRISMA 2020指南的系统综述,纳入42项直接评估MAGL与物质暴露的临床前研究。
主要发现
- 慢性物质暴露导致轻度、区域特异性的MAGL蛋白表达变化。
- 海马中酒精增加MAGL水平;纹状体中各物质水平基本不变;前额皮质仅反复兴奋剂暴露后变化。
- 阿片和氯胺酮结果混合且跨区域不一致。
- MAGL抑制持续减少大麻、阿片和尼古丁模型的戒断样行为。
- MAGL抑制对奖赏相关行为影响不一,减少阿片相关奖赏但其他模型效果不一致。
临床怎么用
- 临床前证据提示MAGL抑制可能对物质戒断样状态有潜在作用,但奖赏效应不一致。
- 需进一步理解内源性大麻素系统动态适应(包括大麻素受体功能和2-AG信号)如何塑造成瘾相关行为。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monoacylglycerol lipase (MAGL) is the primary enzyme responsible for the hydrolysis of 2-arachidonoylglycerol (2-AG), which is a key regulator of endocannabinoid system tone, thereby influencing synaptic function and neuroinflammation. These processes are central to the neurobiology of substance use disorders (SUDs), but the contribution of MAGL to addiction remains fragmented across studies. With growing interest in MAGL as a therapeutic and imaging target, a comprehensive synthesis is timely. In this systematic review, we aimed to evaluate whether exposure to substances of abuse alters MAGL expression or activity and whether manipulating MAGL function affects SUD-relevant outcomes. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we screened preclinical studies that assessed MAGL directly in the context of substance exposure. A total of 42 studies met the inclusion criteria. Chronic substance exposure led to modest, region-specific changes in MAGL protein expression. In the hippocampus, alcohol increased MAGL levels. In the striatum, levels were largely unchanged across substances. In the prefrontal cortex, changes were only seen after repeated stimulant exposure. Findings for opioids and ketamine were mixed and inconsistent across regions. MAGL inhibition consistently reduced withdrawal-like behaviors across cannabis, opioid, and nicotine models, but effects on reward-related behaviors were more variable, reducing opioid-related reward while showing less consistent effects in other models. Collectively, these findings from preclinical models of SUDs suggest a more robust role for MAGL in withdrawal-like states than in reward. They highlight the need to better understand the dynamic endocannabinoid adaptations, including cannabinoid receptor function and 2-AG signaling, that shape addiction-related behaviors.
引用
- Jebanesan B, Brouillette K, Browne CJ, et al. The Role of Monoacylglycerol Lipase in Substance Use: A Systematic Review of Preclinical Studies. Biol Psychiatry. 2026. PMID: 42342190. doi:10.1016/j.biopsych.2026.06.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。